Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

RenovoRx

Stock_Research_Today

Community Contributor

Revolutionizing Cancer Treatment

A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.

View narrative

US$4.20

71.9% undervalued

371.30%

Revenue growth p.a.

20 days ago

Apple

Investingwilly

Community Contributor

Apple: A Dying Star with an Overpriced Valuation

Intro Apple Inc. (AAPL) has long been one of the most beloved stocks in the market, celebrated for its sleek products and loyal customer base.

View narrative

US$177.34

19.1% overvalued

14.68%

Revenue growth p.a.

5 days ago

Avino Silver & Gold Mines

Agricola

Community Contributor

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Full disclosure. I am a shareholder at the time of writing this.

View narrative

CA$26.79

86.0% undervalued

78.01%

Revenue growth p.a.

20 days ago

RENK Group

Chris1

Community Contributor

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

In a renewed political landscape where a Trump administration adopts a more interventionist stance toward Ukraine, the United States sharply increases its military aid—providing advanced tank transmissions, power packs, and suspension systems. This pivot alleviates initial concerns among European allies, but it simultaneously reinforces the imperative for Europe to shore up its own defense capabilities.

View narrative

€69.87

14.3% undervalued

15.00%

Revenue growth p.a.

21 days ago

Load previous narratives

Icade

AnalystConsensusTarget

Consensus Narrative from 12 Analysts

Pulse Building Lease With Seine-Saint-Denis Will Boost Portfolio Strength

Key Takeaways Improved rental growth expected from the lease agreement and focus on prime locations may enhance revenue stability. Strategic asset disposals and strong liquidity position could optimize the portfolio and support future earnings.

View narrative

€25.33

10.6% undervalued

10.13%

Revenue growth p.a.

18 days ago

Galiano Gold

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

Nkran Pit And CIL Tanks Will Spur Operational Efficiency

Key Takeaways Increased mining productivity and exploration efforts at key sites are expected to boost future revenue and production efficiency. Strategic infrastructure projects and reduced costs could enhance net margins, earnings performance, and future cash flow.

View narrative

CA$3.47

48.2% undervalued

30.36%

Revenue growth p.a.

18 days ago

ME Group International

AnalystConsensusTarget

Consensus Narrative from 3 Analysts

Revolution Laundry Expansion And New Services Will Drive Future Success

Key Takeaways ME Group International's expansion in laundry operations and new services could boost revenue growth and earnings through diversified offerings. Strategic partnerships and technology upgrades may enhance cash flow visibility, operational efficiency, and support stable long-term growth.

View narrative

UK£2.97

29.7% undervalued

7.52%

Revenue growth p.a.

18 days ago

Kiniksa Pharmaceuticals International

AnalystConsensusTarget

Consensus Narrative from 6 Analysts

Medicare Part D And KPL-387 Trials Will Shape Future Success

Key Takeaways Expansion of ARCALYST's prescriber base and Medicare changes enhance revenue growth and patient uptake in recurrent pericarditis treatment. Financial discipline and manufacturing transition to Samsung Biologics support cost efficiencies and stable net margins.

View narrative

US$36.57

28.2% undervalued

22.07%

Revenue growth p.a.

18 days ago

Axsome Therapeutics

AnalystConsensusTarget

Consensus Narrative from 17 Analysts

R&D Pipeline And NDAs Will Unlock New Approvals

Key Takeaways Ongoing R&D and product launch efforts, including key NDA submissions, may significantly enhance future revenues through new product approvals. Strategic commercial expansion and a digital-centric approach could bolster revenues and earnings growth, with operational efficiencies improving net margins.

View narrative

US$177.12

39.3% undervalued

58.13%

Revenue growth p.a.

18 days ago

Akebia Therapeutics

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

Vafseo And VALOR Study Will Open New Treatment Markets

Key Takeaways Early success of Vafseo and reimbursement coverage expansion likely to drive strong revenue growth and market access. Advancing approval for non-dialysis patients may significantly expand market potential and boost long-term revenue prospects.

View narrative

US$7.30

64.2% undervalued

30.17%

Revenue growth p.a.

18 days ago

Goodyear Tire & Rubber

AnalystConsensusTarget

Consensus Narrative from 6 Analysts

Oklahoma Modernization And Divestitures Will Deliver $750 Million Savings

Key Takeaways Strategic divestitures and leadership changes aim to streamline operations and improve efficiency, effectively reducing costs and increasing net margins. Expanding manufacturing and high-margin product lines are set to support future revenue growth by capturing more premium market share.

View narrative

US$11.54

6.7% undervalued

-0.22%

Revenue growth p.a.

18 days ago

Aurinia Pharmaceuticals

AnalystConsensusTarget

Consensus Narrative from 6 Analysts

Academic Medical Centers Will Expand Lupus Care Opportunities

Key Takeaways Expansion into medical centers and new treatment guidelines may drive higher prescriber engagement and revenue for LUPKYNIS. Pipeline progression and improved lupus nephritis care could boost future growth, positively impacting revenue and margins.

View narrative

US$9.83

16.7% undervalued

16.87%

Revenue growth p.a.

18 days ago

Global-E Online

AnalystConsensusTarget

Consensus Narrative from 14 Analysts

Borderfree And AI Will Expand Consumer Electronics Opportunities

Key Takeaways Expansion into consumer electronics and multi-local offerings boosts revenue growth through diversification and risk management. Investment in AI and revamped services enhances operational efficiency, net margins, and platform value, signaling improved earnings potential.

View narrative

US$50.23

34.2% undervalued

25.72%

Revenue growth p.a.

18 days ago

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

Pulse Building Lease With Seine-Saint-Denis Will Boost Portfolio Strength

Nkran Pit And CIL Tanks Will Spur Operational Efficiency

Revolution Laundry Expansion And New Services Will Drive Future Success

Medicare Part D And KPL-387 Trials Will Shape Future Success

R&D Pipeline And NDAs Will Unlock New Approvals

Vafseo And VALOR Study Will Open New Treatment Markets

Oklahoma Modernization And Divestitures Will Deliver $750 Million Savings

Academic Medical Centers Will Expand Lupus Care Opportunities

Borderfree And AI Will Expand Consumer Electronics Opportunities

Value any company in seconds

Popular companies

Community

Weekly Picks

Revolutionizing Cancer Treatment

Apple: A Dying Star with an Overpriced Valuation

Avino a case for USD$20 per share within 5 years (assuming $3,500 gold, $100 silver and $4 copper).

Riding the Defense Boom RENK Sees Revenue Climb at 15% CAGR by FY 2029

Community Investing Ideas

Pulse Building Lease With Seine-Saint-Denis Will Boost Portfolio Strength

Nkran Pit And CIL Tanks Will Spur Operational Efficiency

Revolution Laundry Expansion And New Services Will Drive Future Success

Medicare Part D And KPL-387 Trials Will Shape Future Success

R&D Pipeline And NDAs Will Unlock New Approvals

Vafseo And VALOR Study Will Open New Treatment Markets

Oklahoma Modernization And Divestitures Will Deliver $750 Million Savings

Academic Medical Centers Will Expand Lupus Care Opportunities

Borderfree And AI Will Expand Consumer Electronics Opportunities

Value any company in seconds

Popular companies